Using chickens for therapeutic and diagnostic monoclonal antibody (mAb) discovery.

Galitex is a team of researchers at The Pirbright Institute. Our mission is to develop therapeutic and diagnostic mAbs by leveraging the advantages of the chicken immune system.

LEARN MORE

Highly conserved mammalian antigens can be poorly immunogenic. Poorly immunogenic targets can fail to yield commercially viable antibodies.

The Galitex Advantage

Broad epitope coverage

High immunogenicity of mammalian antigens in chickens means that the chicken immune system can raise antibodies to epitopes that are otherwise invisible to the immune systems of mammals. Having access to a greater number and diversity of epitopes means chicken mAbs are better positioned to address diverse commercial needs such as therapeutics that act as agonists or antagonists, or that act in concert with mammalian mAbs, or in diagnostics for detection of molecular markers.

This means chickens can generate an antibody repertoire with expanded epitope coverage relative to mammal repertoires.

Having access to a greater number and diversity of specificities means chicken antibodies are better positioned to address diverse commercial needs such as therapeutics that act as agonists or antagonists of receptors.

Pan-mammalian mAbs

Chicken mAbs can recognise epitopes that are conserved across mammal orthologues. Being able to effectively bind rat, mouse, non-human primate, and human antigens means chicken mAbs can be used in preclinical safety trials that avoid the use of non-human primates.

Epitope accessibility

Chicken mAbs have extended heavy chain CDR3 domains that facilitate improved interactions with therapeutic and diagnostic targets.

How Galitex can improve your processes

The benefits of using Chicken Monoclonal Antibodies

INCREASED YIELD

Increased yield of commercially viable antibodies.

QUICKER PRODUCTION

Reduction in delays of your production processes.

REDUCED COSTS

We can reduce your cost through reduced wastage & time savings.

The Galitex Team

Joshua Sealy

Entrepreneurial Lead

Lizelle Gouveneur

Technology Transfer Officer

Simon Graham

Scientific Advisor

Jeffrey Almond

Business Advisor

Get in touch to learn more

Contact us today to learn more about our project and how chicken monoclonal antibodies can be an effective solution for your company.